Aurora Cannabis Inc. (TSE:ACB - Get Free Report) traded up 9.9% during mid-day trading on Thursday . The company traded as high as C$6.92 and last traded at C$6.88. 267,087 shares were traded during mid-day trading, a decline of 54% from the average session volume of 574,670 shares. The stock had previously closed at C$6.26.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Atb Cap Markets raised Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th. TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th. Finally, ATB Capital reduced their price objective on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th.
Get Our Latest Report on Aurora Cannabis
Aurora Cannabis Price Performance
The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 18.72. The stock has a market capitalization of C$357.79 million, a PE ratio of -8.08 and a beta of 2.71. The stock's 50-day moving average is C$6.88 and its 200 day moving average is C$6.94.
Insider Buying and Selling at Aurora Cannabis
In related news, Senior Officer Andre Jerome sold 13,390 shares of the company's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of C$9.30, for a total value of C$124,524.32.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
See Also
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
